Loading...
Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
High-dose therapy and autologous stem cell transplantation (HDT-ASCT) can offer potential long-term remission or cure in patients with non-Hodgkin lymphoma (NHL). Limited experience is available on the safety and efficacy of HDT-ASCT in elderly patients. This is a single-center, retrospective study...
Na minha lista:
| Udgivet i: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5480286/ https://ncbi.nlm.nih.gov/pubmed/25175794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.08.019 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|